AVXL insider transaction filings

ANAVEX LIFE SCIENCES CORP. — 16 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-01-09. Screen AVXL transaction legs live →

FiledFormInsiderReported transactionsSource
2026-01-094Boenisch Sandra — PFO & TreasurerGrant/award (A): 12,500 (derivative) @ $0EDGAR
2026-01-094MISSLING CHRISTOPHER U — President and CEO, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-10-034Boenisch Sandra — PFO & TreasurerGrant/award (A): 12,500 (derivative) @ $0EDGAR
2025-10-034MISSLING CHRISTOPHER U — President and CEO, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-09-124MISSLING CHRISTOPHER U — President and CEO, DirectorOption exercise (M): 187,500 @ $5.04 · Tax withholding (F): 145,048 @ $9.58 · Option exercise (M): 187,500 (derivative) @ $0EDGAR
2025-08-224Boenisch Sandra — PFO & TreasurerGrant/award (A): 12,500 (derivative) @ $0EDGAR
2025-08-224MISSLING CHRISTOPHER U — President and CEO, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-06-094Thomas Steffen — DirectorOption exercise (M): 50,000 @ $1.76 · Tax withholding (F): 11,349 @ $7.75 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-04-304Boenisch Sandra — PFO & TreasurerGrant/award (A): 12,500 (derivative) @ $0EDGAR
2025-04-304MISSLING CHRISTOPHER U — President and CEO, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-04-024Donhauser Peter D.O. — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-04-024Ma Jiong — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-04-024Skarpelos Athanasios — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-04-024Thomas Steffen — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-04-024Velden Claus Vander — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-03-264MISSLING CHRISTOPHER U — President and CEO, DirectorOption exercise (M): 500,000 @ $0.92 · Tax withholding (F): 282,497 @ $9.63 · Option exercise (M): 500,000 (derivative) @ $0EDGAR

Recent 8-K events — ANAVEX LIFE SCIENCES CORP.

FiledFormItems reportedSource
2026-08-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-038-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K8.01 — Other EventsEDGAR
2026-06-268-K8.01 — Other EventsEDGAR
2026-05-228-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-05-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-258-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AVXL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →